PMID: 22563666May 9, 2012Paper

Endothelial progenitor cells (EPCs) and mesenchymal stem cells (MSCs) in bone healing

Current Stem Cell Research & Therapy
Nikolaos C KeramarisNicola Maffulli

Abstract

Fracture healing is a complex physiological process. Local vascularity at the site of the fracture has been established as one of the most important factors influencing the healing process, and lack of vascularity has been implicated in atrophic non unions. Existing research has primarily involved utilising Mesenchymal Stem Cells (MSCs) to augment bone healing but there remains much scope to explore the role of stem cells in the vascularisation process. Endothelial Progenitor Cells (EPCs) and other Endothelial Cellular populations (ECs) could constitute a valid alternative to MSCs. This systematic review is examining the importance of co-implantation of MSCs and EPCs/ECs for bone healing. A literature search was performed using the Cochrane Library, OVID Medline, OVID EMBASE and Google Scholar, searching for combinations of the terms EPCs, Endothelial progenitor cells, angiogenesis, fracture, bone and healing. Finally 18 articles that fulfilled our criteria were included in this review. ECs could be of value for the treatment of critical size bone defects as they are known to be capable of forming ectopic, vascularised bone. The co-implantation of ECs with MSCs is more intriguing when we take into account the vast array of comp...Continue Reading

Citations

Oct 11, 2014·Advances in Wound Care·Alice KingTimothy M Crombleholme
Nov 5, 2013·Mayo Clinic Proceedings·Christopher H Evans
Feb 14, 2015·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Dénes B HorváthyZsombor Lacza
Oct 18, 2016·Frontiers in Physiology·Bipradas RoyHugh M Fentress
Nov 9, 2016·Prostaglandins & Other Lipid Mediators·Elizabeth BerryAustin M Guo
Jan 16, 2014·The Veterinary Quarterly·Baukje A SchotanusBart Spee
Jan 5, 2018·Expert Opinion on Biological Therapy·Isabel AndiaNicola Maffulli
Dec 1, 2017·Frontiers in Physiology·Anne-Margaux CollignonGael Y Rochefort
Sep 25, 2017·Journal of Cellular Physiology·Ling TongJianglong Zhai
Nov 24, 2018·Biofabrication·Yang WuIbrahim T Ozbolat
Sep 24, 2019·Expert Opinion on Biological Therapy·Isabel AndiaNatalia Burgos-Alonso
Dec 19, 2017·British Medical Bulletin·Federico Giuseppe UsuelliNicola Maffulli
Oct 10, 2019·The Journal of Bone and Joint Surgery. American Volume·Jehan J El-JawhariPeter V Giannoudis
Jun 24, 2020·Expert Opinion on Biological Therapy·Filippo MiglioriniNicola Maffulli
Dec 5, 2019·The Journal of Bone and Joint Surgery. American Volume·Jehan J El-JawhariPeter V Giannoudis
Apr 22, 2018·Stem Cell Research & Therapy·Alessandro PirosaRocky S Tuan
Feb 12, 2020·Scientific Reports·V GoranovV A Dediu
Feb 6, 2021·Journal of Orthopaedic Surgery and Research·Jong Woo KangJong Woong Park
Jan 24, 2021·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Florian BöhrnsenHenning Schliephake
Sep 14, 2021·Frontiers in Bioengineering and Biotechnology·Siddharth ShanbhagKamal Mustafa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.